¥14.00 ($2.09)

+0.26 (+1.89%)

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · ¥20.9B mcap · 736M float · 1.99% daily turnover

Revenue

$8.2B -3.1% ▼

5Y CAGR: -9.5%

Gross Profit

$5.5B -3.2% ▼

5Y CAGR: +0.2%

Operating Income

$1.4B +25.5% ▲

5Y CAGR: -1.7%

Net Income

$1.1B +15.7% ▲

5Y CAGR: -0.4%

EPS (Diluted)

$0.74 +15.6% ▲

5Y CAGR: -0.3%

EBITDA

$1.7B +13.5% ▲

5Y CAGR: -2.1%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$8.0B	$8.6B	$8.7B	$8.5B	$8.2B
YoY Growth	-41.4%	+8.6%	+0.4%	-2.0%	-3.1%
Cost of Revenue	$2.7B	$3.1B	$2.9B	$2.8B	$2.7B
Gross Profit	$5.3B	$5.5B	$5.8B	$5.7B	$5.5B
Gross Margin	66.3%	63.6%	66.7%	66.9%	66.9%
R&D Expenses	$580M	$845M	$917M	$830M	$0
SG&A Expenses	$3.3B	$3.3B	$3.3B	$3.3B	$3.3B
Operating Expenses	$2.5B	$5.7B	$4.6B	$4.6B	$4.2B
Operating Income	$2.7B	-$160M	$1.2B	$1.1B	$1.4B
Operating Margin	34.4%	-1.9%	14.2%	12.7%	16.4%
Interest Expense	$81M	$70M	$87M	$65M	$34M
Income Before Tax	$2.7B	-$168M	$1.2B	$1.1B	$1.3B
Tax Expense	$316M	$181M	$204M	$210M	$284M
Net Income	$2.4B	-$264M	$1.1B	$956M	$1.1B
Net Margin	29.7%	-3.1%	12.3%	11.2%	13.4%
EPS (Diluted)	$1.57	$-0.18	$0.72	$0.64	$0.74
EBITDA	$1.6B	$1.8B	$1.9B	$1.8B	$1.7B
Shares Outstanding	1.50B	1.50B	1.49B	1.49B	1.49B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$2.1B	$2.0B	$2.1B	$2.2B	$2.0B	$1.9B	$2.2B	$2.0B
Cost of Revenue	$724M	$664M	$686M	$713M	$684M	$647M	$624M	$596M
Gross Profit	$1.4B	$1.4B	$1.4B	$1.5B	$1.3B	$1.3B	$1.5B	$1.4B
Gross Margin	65.4%	67.4%	66.6%	68.1%	66.2%	66.4%	71.2%	70.7%
R&D Expenses	$194M	$265M	$203M	$140M	$210M	$553M	$192M	$117M
SG&A Expenses	$831M	$882M	$803M	$872M	$844M	$2.5B	$874M	$59M
Operating Expenses	$1.2B	$1.3B	$956M	$1.0B	$1.1B	$1.1B	$1.1B	$854M
Operating Income	$205M	$76M	$413M	$499M	$247M	$196M	$453M	$586M
Operating Margin	9.8%	3.7%	20.1%	22.4%	12.2%	10.2%	20.9%	28.8%
Interest Expense	$10M	$1M	$12M	$7M	$7M	$5M	$3M	$4M
Income Before Tax	$204M	$72M	$408M	$497M	$248M	$192M	$462M	$585M
Tax Expense	$29M	$41M	$76M	$39M	$45M	$124M	$97M	$65M
Net Income	$180M	$113M	$314M	$460M	$210M	$121M	$370M	$522M
Net Margin	8.6%	5.6%	15.3%	20.6%	10.4%	6.3%	17.1%	25.7%
EPS (Diluted)	$0.12	$0.08	$0.21	$0.31	$0.14	$0.08	$0.25	$8.50
EBITDA	$442M	$284M	$438M	$558M	$354M	$480M	$453M	$586M
Shares Outstanding	1.49B	1.49B	1.49B	1.49B	1.49B	1.50B	1.49B	62M

600535.SS SHH